Compounded semaglutide is a prescription medication that a compounding pharmacy makes from scratch. The pharmacy mixes semaglutide with a sterile liquid and, in some formulations, additional ingredients, then dispenses it in a vial or prefilled syringe.
People often consider compounded semaglutide because it costs less than branded semaglutide. During the national semaglutide shortage, compounded products also gave some patients access when Ozempic and Wegovy were difficult to find.
Access has changed since then. The FDA declared the shortage resolved in February 2025. Compounding pharmacies for semaglutide now have limits on making compounded products that closely copy Ozempic and Wegovy.
Compounding may still be appropriate for a patient with a specific medical need. However, compounded semaglutide is not approved by the FDA. Its formula, quality, and ingredients can differ from one pharmacy to another. These differences affect safety, cost, dosing, and results.
What is compounded semaglutide?
Compounded semaglutide is a medicine prepared by a compounding pharmacy. This means a pharmacy prepares a semaglutide medication from scratch instead of dispensing a readily available drug like Ozempic or Wegovy made by a manufacturer.
Drug compounding is the process of preparing a medication for a specific patient. A pharmacist may combine, mix, dilute, or adjust ingredients based on a prescription.
For example, a patient may need a liquid medication because they cannot swallow a commercially available tablet. Another patient may need a medication made without a dye that causes an allergic reaction. Compounding can meet these individual medical needs.
A typical semaglutide compound injection follows a process similar to this:
-
- A licensed prescriber evaluates the patient.
- The prescriber determines that semaglutide is appropriate.
- The prescriber writes a patient-specific prescription.
- A licensed pharmacy prepares the prescribed formulation.
- The pharmacy labels and dispenses the medication.
- The patient receives instructions for measuring, injecting, and storing it.
The exact process depends on the pharmacy, prescription, and state rules.
What is in compounded semaglutide?
The ingredients vary, but a basic compounded semaglutide injection may contain:
-
- Semaglutide
- Sterile liquid
- Buffering or stabilizing ingredients
- A preservative when appropriate for the formulation
Some pharmacies add another active ingredient, such as:
-
- Cyanocobalamin, a form of vitamin B12
- Pyridoxine, a form of vitamin B6
- Glycine, an amino acid
- Niacinamide, a form of vitamin B3
- Levocarnitine
- Nicotinamide adenine dinucleotide, commonly called NAD
The FDA has stated that the safety and effectiveness of combining semaglutide with ingredients such as vitamin B12, vitamin B6, levocarnitine, or NAD have not been established.
When checking what is in compounded semaglutide, the drug label should show the active ingredients, their concentrations, the dispensing pharmacy, the lot number, the beyond-use date, and storage instructions.
What form of semaglutide should the compounded product contain?
FDA-approved semaglutide products use the base form of semaglutide.
The FDA has warned that some compounded products may contain semaglutide sodium or semaglutide acetate. These salt forms are different active ingredients from the semaglutide base used in Ozempic or Wegovy.
The FDA says it does not have information showing that these salt forms have the same chemical and pharmacologic properties as the approved active ingredient. It is also unaware of a lawful basis for using these salt forms in compounding.
To ensure quality, ask your compounding pharmacy which form they use.
How much does compounded semaglutide cost?
The cost of compounded semaglutide has commonly ranged from about $100 to $300 per month through US telehealth and weight-management programs. Some clinics charge more, especially when laboratory tests, appointments, coaching, or higher doses are billed separately.
Pricing changes frequently because the legal availability of compounded semaglutide has narrowed since the shortage ended.
When comparing prices, look for:
-
- medication cost
- consultation fee
- monthly membership
- laboratory fees
- shipping
- supplies such as syringes
- dose-related price increases
- cancellation charges
- follow-up appointments
A program advertising $99 per month may require several months of prepayment. Another may advertise a low starting price but has hidden charges.
Price of compounded semaglutide vs. Ozempic and Wegovy
As of June 2026, the US list price was approximately $1,027.51 for a one-month supply of Ozempic and $1,349.02 for Wegovy. Insurance, savings cards, and manufacturer self-pay programs can lower those amounts.
Novo Nordisk’s self-pay program lists standard monthly prices of $349 for many Wegovy doses and $349 to $499 for Ozempic injection, depending on dose. Temporary introductory prices and eligibility rules may apply.
| Option | Approximate cash cost |
|---|---|
| Compounded semaglutide program | Often $100 to $300 monthly |
| Ozempic list price | About $1,027.51 monthly |
| Wegovy list price | About $1,349.02 monthly |
| Manufacturer self-pay programs | Often $149 to $499 monthly |
Does compounded semaglutide work for weight loss?
Compounded semaglutide can support weight loss when the product really contains the active semaglutide ingredient at the prescribed strength and the patient responds to treatment. But the amount of weight lost varies widely.
A 2025 study tested 94 adults who received weekly compounded semaglutide with B12 through a commercial wellness program.
After three months:
-
- Average weight loss was 4.11 kg, or about 9.1 lbs
- Average percentage weight loss was 4.57%
- About 45% lost at least 5% of their starting weight
- About 5% lost at least 10%
- Participants lost an average of 2.67 kg of fat mass
- Participants also lost some lean mass and skeletal muscle mass
In another study, patients using compounded semaglutide lost an average of 9.11% of their starting weight. Almost 45% of patients reached at least 10% weight loss, and 12.78% of patients reached at least 15% weight loss.
Note that compounded semaglutide results depend on several factors, including:
-
- whether the product contains the correct active ingredient
- the concentration and accuracy of the dose
- how gradually the dose is increased
- how consistently the patient uses it
- starting weight and health conditions
- nutrition and physical activity
- side effects
- other medications
- length of treatment
- individual biological response
When looking for compounded semaglutide reviews, identify the dispensing pharmacy, formulation, concentration, and their length of treatment. Also ask whether the person followed a structured weight-management program.
Be cautious with websites showing photos of compounded semaglutide before-and-after results. Images may be edited, misleading, or unrelated to the advertised product. They also cannot confirm which medication, dose, pharmacy, treatment period, diet, or exercise plan the person used.
Is compounded semaglutide safe?
Yes, but it depends on the source. The quality of compounded semaglutide can vary, which may increase the risk of incorrect doses and harmful side effects. Fake products have also entered the market.
A secret-shopper study in 2026 examined 75 weight-loss clinics and medical spas selling compounded GLP-1 medications in West Virginia and Oklahoma. More than half offered products mixed with B vitamins, while about 9% offered oral versions like compound semaglutide tablets and sublingual products.
Researchers identified 23 supplying facilities and found that 4 were not licensed to prepare sterile medications. One supplier had received multiple FDA warning letters, and three had faced state disciplinary action.
A 2024 study also found 93 businesses advertising compounded GLP-1 medications across 188 locations in Colorado. Most were medical spas or weight-loss clinics, and nearly all advertised compounded semaglutide.
Researchers found 41 websites mentioned FDA approval when describing compounded products, even though compounded drugs are not FDA-approved, and five called them “generic.” One business advertised a formula containing BPC-157, which the FDA has identified as unsafe for compounding.
Risks of using compounded semaglutide
Compounded drugs carry more risk because the FDA does not review them for safety, quality, or effectiveness before patients receive them. The FDA recommends using compounded semaglutide only when Ozempic, Wegovy, or Rybelsus cannot meet your medical needs.
Risks of using compounded semaglutide include:
1. Dosing errors
Ozempic and Wegovy pens deliver standardized doses. Compounded semaglutide products are often given in a vial, and the patient may need to draw liquid into a syringe.
One pharmacy might dispense 1 mg of semaglutide per milliliter. Another may dispense 2.5 mg per milliliter. The same syringe marking would deliver different semaglutide amounts from those two vials.
The FDA has received reports of patients getting five to 10 times too much compounded semaglutide because doses were incorrectly converted between milligrams, milliliters, and syringe units. In one case, a provider prescribed 25 units instead of 5. In another, three patients received 20 units instead of 2.
These errors caused severe nausea and vomiting. Other reported effects included:
-
- abdominal pain
- dehydration
- fainting
- headache
- pancreatitis
- gallstones
- hospitalization
You should always confirm both the concentration and syringe measurement with the dispensing pharmacy.
2. Some products contain a different form of semaglutide and impurities
Semaglutide sodium and semaglutide acetate differ from the base form used in approved products. A product containing one of these salts should not be described as chemically identical to Ozempic or Wegovy.
Novo Nordisk also reported that some bulk and compounded semaglutide samples contained trace metals, microscopic particles, and chemical impurities that were absent or found at lower levels in its approved products. Several samples contained more than 15% formaldehyde-related impurities, while one compounded product contained 33% unknown impurities.
These substances may cause semaglutide to break down or clump and could increase the risk of an immune reaction. Not every compounded product has these problems, but ingredient quality can vary between suppliers.
3. Fraudulent products
The FDA has found fake compounded semaglutide with false pharmacy information on their labels. Some listed pharmacies did not exist, while others used the name of a licensed pharmacy that did not make the product. One person developed redness, swelling, pain, and a lump after injecting a falsely labeled product.
Avoid semaglutide, tirzepatide, or retatrutide sold as “research use only” or “not for human consumption.”
The pharmacy listed on your medication should be verifiable through the relevant state board of pharmacy. Contact that pharmacy directly if you have questions about the lot, concentration, appearance, or instructions.
4. Packaging and storage concerns
Injectable semaglutide products require refrigeration. The FDA has received complaints about compounded medications arriving warm or with inadequate ice packs.
Some compounded semaglutide products may come in vials or syringes that provide limited protection from light, air, and moisture. Repeatedly puncturing a multidose vial can also expose the medication to air, which may cause oxidation and weaken the peptide.
Testing has also found that certain container materials can affect the solution or release substances such as silicone oil into it. These problems may cause semaglutide to break down, become less effective, or create additional safety concerns.
5. Adverse events may be underreported
Side effects of compounded semaglutide can be similar to those of branded versions. However, they carry additional risks because formulas vary and are not FDA-reviewed. As of May 31, 2026, the FDA had received 990 reports of adverse events associated with compounded semaglutide.
The total may also understate the number of events because many traditional state-licensed pharmacies do not have a federal requirement to report adverse events to the FDA.
Report side effects, medication errors, or product-quality problems to the FDA through the MedWatch program. You can submit a report online or fax the completed form to 1-800-FDA-0178. You may also contact the FDA’s Division of Drug Information at druginfo@fda.hhs.gov or 855-543-3784.
What are the side effects of compounded semaglutide?
The side effects of semaglutide compound injections can include the effects associated with semaglutide itself, as well as problems related to the compounded formulation or injection process.
These include:
-
- nausea
- vomiting
- diarrhea
- constipation
- stomach pain
- indigestion
- burping
- headache
- tiredness
More serious problems may include:
-
- Pancreatitis
- Gallbladder problems
- Kidney injury related to dehydration
- Severe stomach or intestinal symptoms
- Serious allergic reactions
- Low blood sugar when combined with insulin or certain diabetes medicines
- Changes in diabetic eye disease
- Complications related to delayed stomach emptying
Commercially available semaglutide products also carry a boxed warning on thyroid C-cell tumors observed in rodents. It is unknown whether semaglutide causes these tumors in humans. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use semaglutide.
Current semaglutide guidance advises stopping the medication at least two months before a planned pregnancy.
Is compounded semaglutide the same as Ozempic or Wegovy?
No, compounded semaglutide is not the same as Ozempic or Wegovy.
Ozempic and Wegovy are FDA-approved brand-name medications made by Novo Nordisk.
Before approval, these drugs undergo laboratory testing and several phases of clinical trials to evaluate their dosage, safety, and effectiveness. The FDA also reviews manufacturing quality and labeling. Compounded medications do not go through this approval process or product-specific clinical trials before being dispensed.
An Australian study compared patients who received compounded or commercially produced semaglutide. After four months, patients receiving commercially produced semaglutide lost more weight.
Those who used compounded semaglutide lost an average of 9.11% of their starting weight, compared with 9.87% among those using commercial semaglutide. Fewer patients in the compounded group reached at least 10% weight loss (44.64% vs. 50.54%) or 15% weight loss (12.78% vs. 21.42%).
Compounding pharmacy vs. brand name semaglutide
A compounded product is prepared by a specialized pharmacy. Novo Nordisk does not manufacture it, and the FDA does not approve the finished formula.
| Feature | Compounded semaglutide | Ozempic, Wegovy, and Rybelsus |
|---|---|---|
| Ingredients | Semaglutide, sometimes with added vitamins or amino acids | Semaglutide |
| Testing and FDA approval | No | Yes |
| Product source | Compounding pharmacy | Novo Nordisk |
| Injection delivery | Vials and prefilled syringes | Prefilled pens |
| Dosage forms | Injections, oral pills, sublingual drops or pills, nasal sprays, and patches | Prefilled pens and oral tablets |
| Dosage strengths | Varies |
Ozempic injection: 0.25 mg, 0.5 mg, 1 mg, and 2 mg Ozempic tablets: 1.5 mg, 4 mg, and 9 mg Rybelsus tablets: 3 mg, 7 mg, and 14 mg Wegovy injection: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, and 7.2 mg Wegovy tablets: 1.5 mg, 4 mg, 9 mg, and 25 mg |
Are all semaglutide the same?
No. Semaglutide products may contain the same active ingredient, but they can differ in dose, formulation, approved use, delivery device, and quality controls.
-
- Ozempic, Wegovy, and Rybelsus are FDA-approved brand-name semaglutide medications.
-
- Generic semaglutide would also require FDA approval and must meet standards for equivalence to the brand product.
-
- Compounded semaglutide is custom-made by a compounding pharmacy and does not undergo FDA approval.
Is compounded semaglutide the same as a generic?
No, compounded semaglutide is not a generic. The FDA reviews a generic drug before approval. The manufacturer must meet requirements involving quality, strength, dosage form, performance, and equivalence to the reference product.
As of July 2026, there is no FDA-approved generic semaglutide equivalent to Ozempic or Wegovy in the United States. But other countries like Canada have begun approving generic semaglutide products.
Is compounding semaglutide legal in 2026?
Yes, legal compounding remains available under specific federal and state conditions. A state-licensed pharmacy may prepare it for an individual patient when a prescriber documents a medically necessary difference.
Will compounded semaglutide be banned?
Compounded semaglutide has not received a nationwide ban.
Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a state-licensed pharmacy may compound semaglutide for a patient based on a prescription. But the pharmacy cannot regularly make large amounts of it.
They also can’t make a product that is essentially a copy of Ozempic, Wegovy, or Rybelsus. Your prescriber has to document a medically necessary change. For example, a need to change an inactive ingredient like a preservative due to an allergy. In April 2026, the FDA clarified that adding an ingredient such as vitamin B12 does not prevent a formulation from being treated as an essentially copied product.
In short, access to compounded semaglutide is more restricted than it was during the shortage.
How to find a legitimate semaglutide compounding pharmacy?
A simple search for a “semaglutide compounding pharmacy near me” can produce clinics, medical spas, telehealth companies, pharmacies, and unlicensed sellers. Verify who actually prepares and dispenses the medication. Also avoid searching for the cheapest semaglutide compounding pharmacy. Do not choose based on price alone.
When looking for pharmacies that compound semaglutide, check the following:
Confirm the pharmacy license
Search the pharmacy through the board of pharmacy in the state where it operates. Confirm that the license is active and that the address matches the label. If the pharmacy ships across state lines, it may also need a nonresident pharmacy license in your state.
Identify the prescriber
A legitimate service should tell you who evaluated you and provide that clinician’s professional credentials. Avoid services that approve everyone through a short questionnaire without meaningful review of medical history, current medications, contraindications, and treatment options.
Ask what form of semaglutide it uses
Ask whether the active ingredient is semaglutide base, semaglutide sodium, or semaglutide acetate.
Also ask:
-
- Where the active ingredient comes from
- Whether the pharmacy tests potency and sterility
- Whether it can provide a certificate of analysis
- What concentration the vial contains
- Which added ingredients are present
- How the medication should be stored
- What to do if it arrives warm
Watch for online-sales warnings
According to the FDA, advertisements for prescription drugs, including compounded medications, must be accurate and cannot mislead patients.
Avoid sellers that:
-
- Do not require a prescription
- Sell semaglutide through social media messages
- Accept cryptocurrency as the only payment
- Label the product “research use only”
- Offer powder for home mixing
- Claim their product is identical to Ozempic or Wegovy
- Refuse to name the pharmacy
- Provide no licensed clinician for questions
- Ship an injectable without suitable temperature control
- Use a pharmacy name that cannot be verified
You should not purchase semaglutide without a prescription. A legitimate US pharmacy requires a valid prescription from an authorized clinician.
How to use compounded semaglutide?
Your prescription label should state the semaglutide dose and the volume to inject. Follow the directions for your specific vial or syringe.
There is no standard compounded semaglutide dosing chart because pharmacies can prepare different concentrations. For example, 10 syringe units from one vial may contain a different semaglutide dose than 10 units from another vial. “Units” describe liquid volume on an insulin syringe. They do not describe a fixed number of milligrams of semaglutide.
Before every injection:
-
- Check the semaglutide concentration.
- Read the prescribed dose in milligrams.
- Confirm the volume or syringe marking with the pharmacy.
- Inspect the liquid for unexpected color, cloudiness, or particles.
- Use the syringe size supplied or recommended by the pharmacy.
- Follow the storage and injection instructions.
- Record the dose after using it.
Ask the pharmacist to demonstrate how to measure the dose if you have any doubt. Do not recalculate the dose from an online chart.
Does compounded semaglutide need to be refrigerated?
Yes, semaglutide injections need refrigeration.
Semaglutide can lose stability when exposed to excessive heat, freezing, or repeated temperature changes. Once prepared as a liquid, it should generally be refrigerated at 36°F to 46°F (2°C to 8°C) and should not be frozen. Exposure to temperatures above 86°F (30°C) may also damage it.
Storage limits from Ozempic and Wegovy do not automatically apply to every compounded formula, so the label should tell you:
-
- The required temperature
- Whether the medication can spend time at room temperature
- How to protect it from light
- The expiration date
- How long the vial remains usable after the first puncture
If the medication arrives warm, freezes, or stays outside the recommended temperature range, contact the dispensing pharmacy before using it.
Some pharmacies have provided questionable instructions, such as keeping compounded semaglutide at room temperature or repeatedly freezing and thawing it. These practices may affect the medication’s strength and safety.
How long does compounded semaglutide last in the fridge?
Use it only until the beyond-use date on the pharmacy label. If the compounded semaglutide product meets the Category 3 sterile-compounding requirements, it can have a maximum beyond-use date of 120 days. Longer storage may cause semaglutide to break down or form clumps.
Reports from Novo Nordisk found compounded semaglutide products with unusually long beyond-use dates. Some exceeded 180 days, and one pharmacy gave its semaglutide products a use-by date of nearly one year. Such long dates may not be supported by proper safety and stability testing.
Frequently Asked Questions
Articles you may also be interested in
